|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 39/39591 | (2013.01) | ||
| C07K 16/2803 | (2013.01) | ||
| C07K2317/14 | (2013.01) | ||
| C07K2319/55 | (2013.01) |
| (11) | Patento numeris | 3494992 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18200555.3 |
| Europos patento paraiškos padavimo data | 2013-12-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-06-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-07-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261740111 P | 2012-12-20 | US |
| (72) |
HUNTER, Alan , US
LINKE, Thomas , US
PABST, Tim , US
WENDELER, Michaela , US
WANG, Xiangyang , US
THOMPSON, Chris , US
XI, Guoling , US
FULTON, Andrew , US
|
| (73) |
Medimmune Limited ,
Milstein Building
Granta Park, Cambridge CB21 6GH,
GB
|
| (54) | REFOLDING AND PURIFICATION OF MOXETUMOMAB PASUDOTOX |
| REFOLDING AND PURIFICATION OF MOXETUMOMAB PASUDOTOX |